These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28133891)

  • 1. The effects of hydroporation on melasma with anti-aging cocktail.
    Chae JB; Yang SH; Byun SY; Choi HR; Shin JW; Park KC
    J Cosmet Dermatol; 2017 Dec; 16(4):e15-e20. PubMed ID: 28133891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The increase of interfollicular epidermal stem cells and regulation of aryl hydrocarbon receptor and its repressors in the skin through hydroporation with anti-aging cocktail.
    Shin JW; Choi HR; Yang SH; Choi JY; Na JI; Huh CH; Park KC
    J Cosmet Dermatol; 2019 Aug; 18(4):1133-1139. PubMed ID: 30381873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper-GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation).
    Byun SY; Chae JB; Na JI; Park KC
    J Cosmet Laser Ther; 2016 Oct; 18(5):293-5. PubMed ID: 27064823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral tranexamic acid on erythema index in patients with melasma.
    Nguyen J; Rajgopal Bala H; Ross A; Wong CC; Paul E; Rodrigues M
    Australas J Dermatol; 2021 May; 62(2):206-209. PubMed ID: 33125702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and possible mechanisms of topical tranexamic acid in melasma.
    Kim SJ; Park JY; Shibata T; Fujiwara R; Kang HY
    Clin Exp Dermatol; 2016 Jul; 41(5):480-5. PubMed ID: 27135282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation.
    Na JI; Choi SY; Yang SH; Choi HR; Kang HY; Park KC
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1035-9. PubMed ID: 22329442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
    Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
    J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.
    Kim HJ; Moon SH; Cho SH; Lee JD; Kim HS
    Acta Derm Venereol; 2017 Jul; 97(7):776-781. PubMed ID: 28374042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oral tranexemic acid in refractory melasma: A clinico-immuno-histopathological study.
    Nagaraju D; Bhattacharjee R; Vinay K; Saikia UN; Parsad D; Kumaran MS
    Dermatol Ther; 2018 Sep; 31(5):e12704. PubMed ID: 30253023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of oral tranexamic acid and Glycyrrhizin compound in the treatment of recalcitrant Riehl's melanosis.
    Xu Z; Xing X; Zhang C; Chen L; Flora Xiang L
    J Cosmet Dermatol; 2019 Feb; 18(1):286-292. PubMed ID: 30341831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
    Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
    J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melasma: systematic review of the systemic treatments.
    Zhou LL; Baibergenova A
    Int J Dermatol; 2017 Sep; 56(9):902-908. PubMed ID: 28239840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of mild to moderate facial melasma with the Lumixyl topical brightening system.
    Hantash BM; Jimenez F
    J Drugs Dermatol; 2012 May; 11(5):660-2. PubMed ID: 22527440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma.
    Tsilika K; Levy JL; Kang HY; Duteil L; Khemis A; Hughes R; Passeron T; Ortonne JP; Bahadoran P
    J Drugs Dermatol; 2011 Nov; 10(11):1260-4. PubMed ID: 22052305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tranexamic acid for the treatment of melasma.
    Ali FR
    Clin Exp Dermatol; 2019 Apr; 44(3):347-349. PubMed ID: 30484898
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of tranexamic acid in the treatment of melasma.
    Bagherani N
    Dermatol Ther; 2015; 28(4):265. PubMed ID: 25649261
    [No Abstract]   [Full Text] [Related]  

  • 19. Tranexamic Acid for Adults with Melasma: A Systematic Review and Meta-Analysis.
    Zhang L; Tan WQ; Fang QQ; Zhao WY; Zhao QM; Gao J; Wang XW
    Biomed Res Int; 2018; 2018():1683414. PubMed ID: 30533427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.